IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kalehua Capital Management LLC

Q4 2025 Holdings

Filed 2026-02-13 | 19 holdings | $101.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alpha Architect 1-3 Month Box Etf(BOXX)ALPHA ARCH 1-302072L565$26.6M230,78726.3%
X4 Pharmaceuticals Inc(XFOR)COM NEW98420X202$14.9M3,722,84014.7%
Sionna Therapeutics Inc(SION)COM829401108$8.1M197,0728.0%
Relay Therapeutics Inc(RLAY)COM75943R102$7.6M901,4577.5%
Compass Pathways Plc(CMPS)SPONSORED ADS20451W101$5.7M819,6925.6%
Pharvaris NV(PHVS)COMN69605108$5.5M198,7725.5%
Septerna Inc(SEPN)COM81734D104$5.4M194,5445.4%
Oruka Therapeutics Inc(ORKA)COM687604108$3.6M118,5243.6%
Inhibikase Therapeutics Inc(IKT)COM NEW45719W205$3.6M1,750,0003.5%
Allogene Therapeutics Inc(ALLO)COM019770106$3.5M2,546,1293.5%
LeonaBio Inc(LONA)COM04746L203$3.0M393,7012.9%
MoonLake Immunotherapeutics(MLTX)CLASS A ORD61559X104$2.3M175,7342.3%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$2.2M267,0592.2%
Verrica Pharmaceuticals Inc(VRCA)COM SHS92511W207$2.0M235,7791.9%
Tyra Biosciences Inc(TYRA)COM90240B106$2.0M74,4651.9%
Surrozen Inc(SRZN)COM NEW86889P208$1.9M385,1781.9%
Tenaya Therapeutics Inc(TNYA)COM87990A106$1.4M2,000,0001.4%
Kalaris Therapeutics Inc(KLRS)COM482929106$1.2M139,9011.2%
Diamedica Therapeutics Inc(DMAC)COM NEW25253X207$759.1K95,3590.8%